Award ceremony in Morocco on 27th November 2017
Doha: Qatar Biomedical Research Institute (QBRI), part of Hamad Bin Khalifa University (HBKU), won the prestigious Arab Best Research Institution of the Year 2017 award, confirming the institute's position as a pioneer in the provision of healthcare solutions in Qatar, the region, and the world. The award was presented at a celebratory ceremony in Marrakech, Morocco.
Arab Best Awards' General Secretariat and Experts Committee also selected QBRI Acting Executive Director Dr Omar El Agnaf as one of the Best 100 Arab CEOs, in recognition of his contributions to research on Parkinsons disease and related disorders, as well as his vision as QBRIs manager.
The annual Arab Best Awards are among the most coveted in the region, and aim to recognize exceptional organizations and professionals in the Arab world. They aim to celebrate achievements in three core areas: business excellence; government, leadership and sports; and social and community contribution. Award categories are highly competitive and the winners are selected based on a merit system that includes 17 criteria such as leadership style; alignment to strategic business goals; administrative productivity, among others.
For QBRI, the award was a direct result of the institute's ongoing research efforts to provide new insights into the molecular basis of the grand challenges of breast cancer, diabetes and neurological disorders such as autism and neurodegenerative diseases.
"I am delighted that QBRI has been declared the Arab Best Research Institution of the Year for 2017," QBRI Acting Executive Director Dr Omar El Agnaf said.
"Receiving this award is proof of our enduring efforts to contribute to biomedical research in Qatar and the world. It is another example of the hard work and dedication of QBRI's employees and researchers, and solidifies HBKUs position as a research-intensive university. This recognition inspires us to achieve greater milestones, as we continue to pursue solutions for global health challenges," he added.
QBRI’s Appreciation Ceremony on 24th January 2018
To further recognize the prestigious award, a celebratory event was held at the HBKU Research Complex on January 24th. In attendance were Dr. Mohammed Bin Hamad Bin J. Al-Thani, Director of Public Health at the Ministry of Public Health; Dr Abdulla al-Hamaq, Executive Director at Qatar Diabetes Association; Dr. Mohammed Alsayrafi , General Manager, Anti-Doping Lab Qatar; Dr. Asma Al Thani, Dean of the College of Health Sciences at Qatar University, Chairperson of Qatar Genome Programme Committee and Board Vice-Chairperson of Qatar Biobank; Mr. Jim Beck, Chief Human Capital Officer of Qatar Foundation; Dr. Ahmad M. Hasnah, President of HBKU; Dr. Richard O’Kennedy, VP for Research at HBKU; and Dr. César O. Malavé, Dean and Professor in the Chemical Engineering Program at Texas A&M University at Qatar. Other local stakeholders included Hamad Medical Corporation, Shafallah Center, and Sidra Medicine.
The ceremony concluded with a tour of QBRI’s state-of-the-art research facilities.